Skip To Main Content
{ "isEditMode": false, "isPublic": true, "context": "", "site": "campus-sanofi-au", "currentLocale": "en_AU", "translationsPath": "" }
[{ event: `metadata`,device: /(tablet|ipad|playbook|silk)|(android(?!.*mobi))/i.test(navigator.userAgent) ? 'tablet' : (/Mobile|iP(hone|od)|Android|BlackBerry|IEMobile|Kindle|Silk-Accelerated|(hpw|web)OS|Opera M(obi|ini)/.test(navigator.userAgent) ? 'mobile' : 'desktop'),platform: `magnolia`,language: `en`,pageName: `Manage Consents / Unsubscribe` }]
This platform is for Australian healthcare professionals only
Campus
Science
Patient Support
Products
Login
Registration
Science
Anticoagulation
Dermatology
Rare Blood Disorders
Rare Disease
Respiratory
Oncology
Diabetes
Immunisations
Medical education
Neurology
Anticoagulation
Video Library
Content Library
Dermatology
Atopic Dermatitis
Rare Blood Disorders
ALPROLIX
ELOCTATE
Support
Resource Centre
Rare Disease
Fabry Disease
Pompe Disease
Diagnostic Testing
Fabry Disease
Content Library
Pompe Disease
Video Library
Content Library
Respiratory
Content Library
Asthma
CRSwNP
Asthma
Comorbid Severe Asthma and CRS/NP
Results from VESTIGE
Expert perspectives on the evolving asthma landscape
Diabetes
Content Library
Video Library
Diabetes Clinical Paper Summaries
Diabetes Congress Reports
Want to lead in diabetes care? Join us at ADC 2025
Immunisations
Diseases - Immunisations
Travel Map
Immunisations Site Tour
Diseases - Immunisations
Cholera
Diphtheria
Haemophilus influenza type b (Hib)
Hepatitis-A
Hepatitis-B
Influenza
Japanese encephalitis
Measles
Meningococcal disease
Pertussis
Poliomyelitis
Rabies
Respiratory Syncytial Virus (RSV)
Tetanus
Typhoid
Yellow fever
Respiratory Syncytial Virus (RSV)
Severe RSV Disease is unpredictable
Medical education
Advent programme
BR1DGE T1D program
Advent programme
ADVENT Aspire
ADVENT Knowledge Centre
ADVENT Respiratory
ADVENT Dermatology
Neurology
NEUROLOGY OPEN ACCESS
LEMTRADA OPEN ACCESS
Patient Support
Anticoagulation
Diabetes
Dermatology
Respiratory
Dermatology
Atopic Dermatitis
Atopic Dermatitis
Patient Support material
Respiratory
Asthma
CRSwNP
Asthma
Video Library
Products
Aldurazyme
Clexane
Cerdelga (eliglustat)
Cerezyme
Dupixent Asthma
Dupixent Atopic Dermatitis
Dupixent CRSwNP
Dupixent Atopic Dermatitis
Elaprase
Fabrazyme
Immunisation Product Hub
Myozyme
Nexviazyme
Dupixent COPD
Optisulin
Toujeo
Cerdelga (eliglustat)
Video - How Does Cerdelga Work?
Video - Switching Patients from ERT to Cerdelga (Clinical Trial Summary)
Video - Real-World Evidence to Support the Use of Cerdelga
Cerdelga Clinical Papers
Dupixent Asthma
Indication and Patient Types
Mechanism of Action
Guide to Prescribing DUPIXENT
Dupixent (dupilumab) dosing guide
ACQ 5 Survey
PBS Prescribing Forms
Dupixent Atopic Dermatitis
HCP Support material
Dupixent CRSwNP
Indication and Patient Types
Mechanism of Action
Guide to accessing DUPIXENT privately
Dupixent Atopic Dermatitis
Atopic Dermatitis
Atopic Dermatitis
hcp-support
Fabrazyme
Fabrazyme Reconstitution and Administration
Immunisation Product Hub
Act-HIB
Adacel
Adacel Polio
Avaxim
Beyfortus
Fluquadri
Fluzone High-Dose Quadrivalent
Ipol
Menquadfi
Quadracel
Stamaril
Tripacel
Typhim Vi
Vaxigrip-Tetra
Verorab
Beyfortus
Manage RSV with Beyfortus
Myozyme
Myozyme Preparation
Myozyme Mechanism of Action (MOA)
Nexviazyme
Resources
Mechanism of Action
Long-Term Durability
Safety
Forced Vital Capacity (FVC)
Six Minute Walk Test (6MWT)
Muscle Strength
Dupixent COPD
Access options
MOA of Dupixent in COPD
Type 2 inflammation in respiratory disease
Dosing and administration
Efficacy
Safety
How eosinophils impact COPD
Campus
Science
Patient Support
Products
Back to main
Science
Anticoagulation
Dermatology
Rare Blood Disorders
Rare Disease
Respiratory
Oncology
Diabetes
Immunisations
Medical education
Neurology
Science
Anticoagulation
Video Library
Content Library
Science
Dermatology
Atopic Dermatitis
Science
Rare Blood Disorders
ALPROLIX
ELOCTATE
Support
Resource Centre
Science
Rare Disease
Fabry Disease
Pompe Disease
Diagnostic Testing
Rare Disease
Fabry Disease
Content Library
Rare Disease
Pompe Disease
Video Library
Content Library
Science
Respiratory
Content Library
Asthma
CRSwNP
Respiratory
Asthma
Comorbid Severe Asthma and CRS/NP
Results from VESTIGE
Expert perspectives on the evolving asthma landscape
Science
Diabetes
Content Library
Video Library
Diabetes Clinical Paper Summaries
Diabetes Congress Reports
Want to lead in diabetes care? Join us at ADC 2025
Science
Immunisations
Diseases - Immunisations
Article
Travel Map
Immunisations Site Tour
Immunisations
Diseases - Immunisations
Article
Cholera
Diphtheria
Haemophilus influenza type b (Hib)
Hepatitis-A
Hepatitis-B
Influenza
Japanese encephalitis
Measles
Meningococcal disease
Pertussis
Poliomyelitis
Rabies
Respiratory Syncytial Virus (RSV)
Tetanus
Typhoid
Yellow fever
Diseases - Immunisations
Respiratory Syncytial Virus (RSV)
Severe RSV Disease is unpredictable
Science
Medical education
Advent programme
BR1DGE T1D program
Medical education
Advent programme
ADVENT Aspire
ADVENT Knowledge Centre
ADVENT Respiratory
ADVENT Dermatology
Science
Neurology
NEUROLOGY OPEN ACCESS
LEMTRADA OPEN ACCESS
Back to main
Patient Support
Anticoagulation
Diabetes
Dermatology
Respiratory
Patient Support
Dermatology
Atopic Dermatitis
Dermatology
Atopic Dermatitis
Patient Support material
Patient Support
Respiratory
Asthma
CRSwNP
Respiratory
Asthma
Video Library
Back to main
Products
Aldurazyme
Clexane
Cerdelga (eliglustat)
Cerezyme
Dupixent Asthma
Dupixent Atopic Dermatitis
Dupixent CRSwNP
Dupixent Atopic Dermatitis
Elaprase
Fabrazyme
Immunisation Product Hub
Myozyme
Nexviazyme
Dupixent COPD
Optisulin
Toujeo
Products
Cerdelga (eliglustat)
Video - How Does Cerdelga Work?
Video - Switching Patients from ERT to Cerdelga (Clinical Trial Summary)
Video - Real-World Evidence to Support the Use of Cerdelga
Cerdelga Clinical Papers
Products
Dupixent Asthma
Indication and Patient Types
Mechanism of Action
Guide to Prescribing DUPIXENT
Dupixent (dupilumab) dosing guide
ACQ 5 Survey
PBS Prescribing Forms
Products
Dupixent Atopic Dermatitis
HCP Support material
Products
Dupixent CRSwNP
Indication and Patient Types
Mechanism of Action
Guide to accessing DUPIXENT privately
Products
Dupixent Atopic Dermatitis
Atopic Dermatitis
Dupixent Atopic Dermatitis
Atopic Dermatitis
hcp-support
Products
Fabrazyme
Fabrazyme Reconstitution and Administration
Products
Immunisation Product Hub
Act-HIB
Adacel
Adacel Polio
Avaxim
Beyfortus
Fluquadri
Fluzone High-Dose Quadrivalent
Ipol
Menquadfi
Quadracel
Stamaril
Tripacel
Typhim Vi
Vaxigrip-Tetra
Verorab
Immunisation Product Hub
Beyfortus
Manage RSV with Beyfortus
Products
Myozyme
Myozyme Preparation
Myozyme Mechanism of Action (MOA)
Products
Nexviazyme
Resources
Mechanism of Action
Long-Term Durability
Safety
Forced Vital Capacity (FVC)
Six Minute Walk Test (6MWT)
Muscle Strength
Products
Dupixent COPD
Access options
MOA of Dupixent in COPD
Type 2 inflammation in respiratory disease
Dosing and administration
Efficacy
Safety
How eosinophils impact COPD
Login
Registration
You are not authorized to access this page as currently authenticated
MAT-AU-2302734 - 1.0 - 12/2023